Overview


Anti-ulcer drugs, also known as gastric acid suppressants or gastroprotective agents, are medications used to treat and manage various types of ulcers in the gastrointestinal tract. These ulcers can occur in the stomach, duodenum (the first part of the small intestine), and other parts of the digestive system. The primary goal of these drugs is to lower the secretion of gastric acid, which can help relieve symptoms and promote the healing of ulcers. The most commonly used anti-ulcer agents are antacids such as aluminum or magnesium hydroxide (Maalox, Mylanta, and many others) and calcium carbonate (Tums, Rolaids, and others). Antacids are minimally absorbed and have no adverse effects on the liver. The utilization of antacids could lead to a slight increase in urinary pH, and in rare cases, the calcium salts might result in hypercalcemia.

The most potent and effective antiulcer drugs are the selective histamine type 2 receptor blockers (H2 blockers) and the proton pump inhibitors (PPIs). These medications operate by blocking the routes of acid generation or release, thereby reducing gastric acidity. This reduction in acidity not only alleviates symptoms but also aids in the healing of acid-peptic diseases. These are some of the most commonly used drugs in medicine and are generally well tolerated and rarely result in serious adverse effects. However, both these classes of drugs have been associated with rare occurrences of acute liver injury.

FutureWise Market Research has published a report that provides an insightful analysis anti-ulcer drug market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, anti-ulcer drug market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Eisai
  • Daewoong Pharmaceutical
  • Takeda
  • HeliCure
  • AstraZeneca
  • Ore Pharmaceuticals
  • Sihuan Pharmaceutical

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Anti-ulcer Drug Market:

• In March 2021- Researchers at Northwell Health in New York City initiated a study to investigate the potential of famotidine, a drug usually prescribed for the treatment of stomach ulcers.

The increasing occurrence of gastric and duodenal ulcers, attributed to modern stress levels, unhealthy dietary patterns, and increasing infections, is anticipated to propel the demand for anti-ulcer drugs market. As these factors are more prevalent in modern lifestyles, the need for effective medical solutions like anti-ulcer medications becomes paramount, thereby driving substantial growth in the market for such drugs. Furthermore, the growing use of herbal drugs for antiulcer activity and standardization of such herbal remedies to be clinically effective and globally competitive. Chemical compounds extracted from plants is used to treat human diseases since the start of medical practices. Recent advancements have renewed interest in natural products for drug discovery. Therefore, efforts should be directed toward isolating and characterizing the active principles and elucidating the relationship between structure and activity. Various medicinal plants and their extracts rich in active chemical constituents, like flavonoids and tannins, have significant antiulcer effects in in-vivo experiments on animal models. Furthermore, the side effects associated with certain anti-ulcer drugs substantially restrain the growth of the anti-ulcer drug market. Despite their therapeutic benefits, the risk of adverse side effects could deter both patients and healthcare providers from opting for these treatments. Concerns over side effects, ranging from mild discomfort to more severe health implications, could lead to cautious prescribing practices and impact patient compliance, thereby hindering the usage and acceptance of such drugs within clinical settings.

By Type

  • Sodium Bicarbonate
  • Magnesium Trisilicate
  • Others

By Application

  • Hospital
  • Medical Center
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Owing to the high prevalence of peptic ulcers, a sizable elderly population, and advanced healthcare infrastructure in the U.S. drive the demand for anti-ulcer drugs in the region. Also, due to high healthcare spending, a surge in R&D activities, and technological advancement, the market in North America is growing. The industry is also anticipated to benefit from a wide range of market players and a rise in novel product approvals. Therefore, the above-mentioned factors are expected to drive the growth of the anti-ulcer drug market during the forecast period in the region.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Anti-ulcer Drug Market By Type, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Anti-ulcer Drug Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Anti-ulcer Drug Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Anti-ulcer Drug Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Anti-ulcer Drug Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Sodium Bicarbonate
        2. Magnesium Trisilicate
        3. Others

  • 8.   Anti-ulcer Drug Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital
        2. Medical Center
        3. Others

  • 9.   North America Anti-ulcer Drug Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Anti-ulcer Drug Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Anti-ulcer Drug Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Anti-ulcer Drug Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Eisai
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Daewoong Pharmaceutical
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Takeda
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. HeliCure
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. AstraZeneca
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Ore Pharmaceuticals
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Sihuan Pharmaceutical
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients